DrugPatentWatch Database Preview

BROMOCRIPTINE MESYLATE Drug Profile

« Back to Dashboard

When do Bromocriptine Mesylate patents expire, and when can generic versions of Bromocriptine Mesylate launch?

Bromocriptine Mesylate is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Paddock Llc, and Sandoz Inc. and is included in six NDAs.

The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.

Summary for BROMOCRIPTINE MESYLATE

US Patents:	0
Applicants:	5
NDAs:	6
Suppliers / Packagers:	9
Bulk Api Vendors:	48
Clinical Trials:	550
Patent Applications:	4,122
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	BROMOCRIPTINE MESYLATE at DailyMed

Pharmacology for BROMOCRIPTINE MESYLATE

Ingredient-type	Ergolines
Drug Class	Ergot Derivative

Medical Subject Heading (MeSH) Categories for BROMOCRIPTINE MESYLATE

Antiparkinson Agents

Dopamine Agonists

Hormone Antagonists

Synonyms for BROMOCRIPTINE MESYLATE

.alpha.-Ergocryptine, methanesulfonate

(+)-Bromocriptine methanesulfonate

(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0;{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),2,9,12,14-penta

(4R,7R)-10-BROMO-N-[(1S,2S,4R,7S)-2-HYDROXY-7-(2-METHYLPROPYL)-5,8-DIOXO-4-(PROPAN-2-YL)-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2,9,12(16),13-

(4R,7R)-10-BROMO-N-[(1S,2S,4R,7S)-2-HYDROXY-7-(2-METHYLPROPYL)-5,8-DIOXO-4-(PROPAN-2-YL)-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2,9,12,14-PENT

(5 inverted exclamation mark |A)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione Methanesulfonate

(5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione mesylate

(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman

(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione

(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman

(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman methanesulfonate

(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman methanesulfonate (salt)

(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman

(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate

(5xi,5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman methanesulfonate (salt)

(5xi,5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate (salt)

(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide

(6AR,9R)-5-bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate

(6aR,9R)-5-Bromo-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quin

08Y

13177-EP2272832A1

13177-EP2275420A1

13177-EP2277876A1

13177-EP2280008A2

13177-EP2287165A2

13177-EP2287166A2

13177-EP2292614A1

13177-EP2292620A2

13177-EP2295412A1

13177-EP2295413A1

13177-EP2295439A1

13177-EP2298731A1

13177-EP2298738A1

13177-EP2298779A1

13177-EP2311808A1

13177-EP2311818A1

13177-EP2311829A1

13177-EP2311837A1

13177-EP2316470A2

13177-EP2316834A1

2-Bromine-alpha-ergocryptine methanesulfonate

2-Bromo |A-Ergocryptine Mesylate

2-Bromo alpha-Ergocryptine Mesylate

2-Bromo-.alpha.-ergocryptine monomethanesulfonate

2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione

2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate

2-Bromo-a-ergocryptine methanesulfonate salt

2-Bromo-alpha-ergocryptine

2-Bromo-alpha-ergocryptine mesylate

2-Bromo-alpha-ergocryptine methanesulfonate

2-Bromo-alpha-ergokryptin

2-Bromo-alpha-ergokryptine

2-Bromo-alpha-ergokryptine-mesilate

2-Bromo-alpha-ergokryptine-mesilate [German]

2-bromoergocriptine

2-Bromoergocryptine

2-Bromoergocryptine Methanesulfonate

2-Bromoergocryptine monomethanesulfonate (salt)

2-Bromoergokryptine

22260-51-1

22260-51-1 (mesylate (salt))

25614-03-3

25614-03-3 (Parent)

3A64E3G5ZO

88085-EP2298415A1

88085-EP2298742A1

88085-EP2305648A1

93201-EP2272825A2

93201-EP2305633A1

AC-13601

AC1L1KXP

AC1L1KXS

AC1Q2716

AK397268

AKOS015896276

AKOS015961273

alpha-Ergocryptine, 2-bromo-, methanesulfonate

Alti-Bromocriptine

AN-17214

Apo-Bromocriptine

B 2134

B6298

Bagren

BC206491

BDBM81993

BIDD:GT0464

Biomol-NT_000005

BPBio1_001131

BRD-K14496212-001-01-1

Bromergocryptine

Bromergon

Bromocriptin

Bromocriptina

Bromocriptina [INN-Spanish]

bromocriptine

Bromocriptine (mesylate)

Bromocriptine (USAN/INN)

Bromocriptine [BAN]

Bromocriptine [USAN:BAN:INN]

Bromocriptine [USAN:INN:BAN]

Bromocriptine mesilate

Bromocriptine mesilate (JP17)

Bromocriptine mesylate (USP)

Bromocriptine mesylate [USAN:USP]

Bromocriptine mesylate [USAN]

Bromocriptine methanesulfonate

Bromocriptine+ (GTP-)

Bromocriptinum

Bromocriptinum [INN-Latin]

Bromocryptin

Bromocryptine

Bromocryptine mesylate

Bromocryptine methanesulfonate

Bromoergocriptine

Bromoergocryptine

C06856

C32H40BrN5O5

C32H40BrN5O5.CH4O3S

CAS-22260-51-1

CAS-25614-03-3

CB 154

CB 154 methanesulfonate (salt)

CB-154

CB-154 mesylate

CCG-204266

CCG-220121

CCG-221475

CCRIS 3244

CHEBI:3181

CHEBI:3182

CHEMBL1200503

CHEMBL493

CS-6048

Cycloset

D00780

D03165

D06YFA

DB01200

DSSTox_CID_197

DSSTox_CID_2687

DSSTox_GSID_20197

DSSTox_GSID_22687

DSSTox_RID_75426

DSSTox_RID_76692

DTXSID1022687

DTXSID6020197

EINECS 244-881-1

EINECS 247-128-5

Ergocryptine, 2-bromo-

Ergocryptine, 2-bromo- (8CI)

Ergocryptine, 2-bromo-(8CI)

ergolactin

Ergoset

Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-

Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-

Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-,(5'-alpha)-

Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-

EU-0100171

FFP983J3OD

GTPL35

HMS1568I04

HMS3260D03

HY-12705A

I06-2158

J-016067

Lopac0_000171

LP00171

LS-64540

LS-7234

MolPort-006-123-738

N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide

NCGC00024584-03

NCGC00024584-04

NCGC00024584-05

NCGC00257268-01

NCGC00260856-01

NCI60_001365

NOJMTMIRQRDZMT-GSPXQYRGSA-N

NSC-169774

NSC169774

oline-9-carboxamide methanesulfonate

OZVBMTJYIDMWIL-AYFBDAFISA-N

Parlodel

Parlodel (TN)

Parlodel Snaptabs

PDSP2_001500

PL001219

PL011661

Pravidel

Prestwick_771

Prestwick0_000121

Prestwick1_000121

Prestwick2_000121

SCHEMBL25297

SCHEMBL40559

SPBio_002101

SR-01000075356

SR-01000075356-1

Tox21_110907

Tox21_303597

Tox21_500171

UNII-3A64E3G5ZO

UNII-FFP983J3OD

ZINC53683151

US Patents and Regulatory Information for BROMOCRIPTINE MESYLATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lek Pharm	BROMOCRIPTINE MESYLATE	bromocriptine mesylate	CAPSULE;ORAL	075100-001	Dec 10, 1998		DISCN	No	No
Mylan	BROMOCRIPTINE MESYLATE	bromocriptine mesylate	TABLET;ORAL	076962-001	Sep 24, 2004	AB	RX	No	No
Mylan	BROMOCRIPTINE MESYLATE	bromocriptine mesylate	CAPSULE;ORAL	077226-001	Apr 4, 2005	AB	RX	No	Yes
Zydus Pharms Usa Inc	BROMOCRIPTINE MESYLATE	bromocriptine mesylate	CAPSULE;ORAL	078899-001	Jul 30, 2008	AB	RX	No	No